US IPO activity saw a meaningful recovery in 2024, with 38% more IPOs and 48% higher proceeds. 2025 may bring even more ...

Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

Public and private M&A are both key for Germany, but it is fair to say that private deals are still dominating the league ...

Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs ...

Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, ...

The Chinese health care technology sector is in the midst of a transformative phase, fueled by breakthroughs in artificial ...

The Hong Kong University of Science and Technology (HKUST) and Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC) together announced the ...

A panel discussion at the Global Life Science Partnering and Investor Conference discusses various strategies and trends in ...

BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ ...

The core of M&A is to find the right target and complete the transaction at a reasonable price range. In cross-border M&A, Goheal helped a medical company acquire a cutting-edge biotechnology company ...

In February, three insiders bought a combined total of $6.61 million in Septerna shares at an average price of $5.79 per ...